Form 8-K - Current report:
SEC Accession No. 0001558370-25-009060
Filing Date
2025-07-02
Accepted
2025-07-02 16:15:15
Documents
12
Period of Report
2025-06-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K dwtx-20250627x8k.htm   iXBRL 8-K 35744
  Complete submission text file 0001558370-25-009060.txt   147677

Data Files

Seq Description Document Type Size
2 EX-101.SCH dwtx-20250627.xsd EX-101.SCH 3433
3 EX-101.LAB dwtx-20250627_lab.xml EX-101.LAB 15924
4 EX-101.PRE dwtx-20250627_pre.xml EX-101.PRE 10039
14 EXTRACTED XBRL INSTANCE DOCUMENT dwtx-20250627x8k_htm.xml XML 4852
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 251101192
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)